From Yahoo Finance: 2025-04-16 17:24:00

Investors are navigating volatile markets, with S&P 500 down 19% from all-time highs. Prime Capital Financial CIO advises diversification with exposure to growth and value stocks, emphasizing balance for stability. Market shifting from “Mag Seven” to Market Weight stocks, signaling need for diversification. International stocks, like Europe and Germany, offer opportunities.

Bristol-Myers Squibb (BMY) is a biopharmaceutical company focusing on oncology, hematology, and other areas. Fiscal 2024 saw strong revenue growth with double-digit increase in growth portfolio. Recent approvals and pipeline advancements position BMY for future growth. Ranked 4th on dirt cheap stocks list, potential lies in AI stocks for higher returns.

BMY’s forward P/E ratio is 7.49 with earnings growth at 489.15% this year. The company reported $12.3 billion in revenue with 8% year-over-year growth, driven by growth portfolio. Recent approvals and pipeline progress add to BMY’s appeal as a dirt cheap stock to invest in now. AI stocks offer even greater potential for higher returns.

Read more: Is Bristol-Myers Squibb Company (BMY) The Dirt Cheap Stock To Invest In Now?